Lawrence C. Paoletti

4.5k total citations
69 papers, 3.0k citations indexed

About

Lawrence C. Paoletti is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Molecular Biology. According to data from OpenAlex, Lawrence C. Paoletti has authored 69 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Public Health, Environmental and Occupational Health, 55 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Lawrence C. Paoletti's work include Neonatal and Maternal Infections (60 papers), Streptococcal Infections and Treatments (53 papers) and Pneumonia and Respiratory Infections (52 papers). Lawrence C. Paoletti is often cited by papers focused on Neonatal and Maternal Infections (60 papers), Streptococcal Infections and Treatments (53 papers) and Pneumonia and Respiratory Infections (52 papers). Lawrence C. Paoletti collaborates with scholars based in United States, Canada and Italy. Lawrence C. Paoletti's co-authors include Dennis L. Kasper, Carol J. Baker, Michael R. Wessels, Harold J. Jennings, Hilde‐Kari Guttormsen, Lawrence C. Madoff, Marcia A. Rench, Francis Michon, Morven S. Edwards and Atul Kumar Johri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Lawrence C. Paoletti

69 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence C. Paoletti United States 32 2.1k 1.9k 473 291 291 69 3.0k
François Peyron France 41 1.2k 0.6× 2.0k 1.1× 845 1.8× 593 2.0× 63 0.2× 157 4.8k
G Wiedermann Austria 28 619 0.3× 692 0.4× 386 0.8× 659 2.3× 80 0.3× 156 2.3k
Maria Aparecida Shikanai‐Yasuda Brazil 36 1.3k 0.6× 3.1k 1.6× 284 0.6× 1.3k 4.5× 46 0.2× 140 3.7k
Roger M. Cole United States 27 558 0.3× 564 0.3× 712 1.5× 302 1.0× 601 2.1× 98 2.4k
José Yuste Spain 27 368 0.2× 1.3k 0.7× 347 0.7× 293 1.0× 666 2.3× 88 2.1k
Daniel Camus France 29 711 0.3× 952 0.5× 341 0.7× 738 2.5× 38 0.1× 72 2.3k
Ali A. Sultan Qatar 26 1.5k 0.7× 554 0.3× 615 1.3× 525 1.8× 50 0.2× 98 3.0k
Sharon L. Reed United States 39 356 0.2× 761 0.4× 793 1.7× 2.3k 7.8× 162 0.6× 104 4.1k
Johannes Blum Switzerland 29 1.9k 0.9× 1.6k 0.9× 282 0.6× 485 1.7× 12 0.0× 76 3.2k
Odile Leroy France 22 542 0.3× 887 0.5× 226 0.5× 221 0.8× 497 1.7× 51 1.7k

Countries citing papers authored by Lawrence C. Paoletti

Since Specialization
Citations

This map shows the geographic impact of Lawrence C. Paoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence C. Paoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence C. Paoletti more than expected).

Fields of papers citing papers by Lawrence C. Paoletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence C. Paoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence C. Paoletti. The network helps show where Lawrence C. Paoletti may publish in the future.

Co-authorship network of co-authors of Lawrence C. Paoletti

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence C. Paoletti. A scholar is included among the top collaborators of Lawrence C. Paoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence C. Paoletti. Lawrence C. Paoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Sizun, et al.. (2012). Regulation and Function of Pilus Island 1 in Group B Streptococcus. Journal of Bacteriology. 194(10). 2479–2490. 34 indexed citations
2.
Guttormsen, Hilde‐Kari, Samantha J. Mascuch, Julia C. West, & Lawrence C. Paoletti. (2009). A fluorescence-based opsonophagocytosis assay to measure the functional activity of antibody to group BStreptococcus. Human Vaccines. 5(7). 461–466. 8 indexed citations
3.
Coyne, Michael J., Maria Chatzidaki‐Livanis, Lawrence C. Paoletti, & Laurie E. Comstock. (2008). Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis. Proceedings of the National Academy of Sciences. 105(35). 13099–13104. 82 indexed citations
4.
Paoletti, Lawrence C., Hilde‐Kari Guttormsen, Mildred S. Christian, Alan M. Hoberman, & Pamela McInnes. (2008). Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits. Human Vaccines. 4(6). 435–443. 7 indexed citations
6.
Johri, Atul Kumar, Lawrence C. Paoletti, Philippe Glaser, et al.. (2006). Group B Streptococcus: global incidence and vaccine development. Nature Reviews Microbiology. 4(12). 932–942. 269 indexed citations
7.
Johri, Atul Kumar, Vilas Patwardhan, & Lawrence C. Paoletti. (2005). Growth rate and oxygen regulate the interactions of group BStreptococcuswith polarized respiratory epithelial cells. Canadian Journal of Microbiology. 51(4). 283–286. 4 indexed citations
8.
Sinha, Anushua, Tracy A. Lieu, Lawrence C. Paoletti, Milton C. Weinstein, & Richard Platt. (2005). The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine. 23(24). 3187–3195. 30 indexed citations
9.
Paoletti, Lawrence C., Darrell L. Peterson, Rachel Legmann, & R. John Collier. (2001). Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen. Vaccine. 20(3-4). 370–376. 17 indexed citations
10.
Baker, Carol J., Lawrence C. Paoletti, Marcia A. Rench, et al.. (2000). Use of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccine for Type II Group BStreptococcusin Healthy Women. The Journal of Infectious Diseases. 182(4). 1129–1138. 88 indexed citations
11.
Paoletti, Lawrence C., et al.. (1999). Synthesis and Preclinical Evaluation of Glycoconjugate Vaccines against Group BStreptococcusTypes VI and VIII. The Journal of Infectious Diseases. 180(3). 892–895. 30 indexed citations
12.
Lachenauer, Catherine S., D. L. Kasper, J Shimada, et al.. (1999). Serotypes VI and VIII Predominate among Group B Streptococci Isolated from Pregnant Japanese Women. The Journal of Infectious Diseases. 179(4). 1030–1033. 148 indexed citations
13.
Kasper, Dennis L., Lawrence C. Paoletti, Michael R. Wessels, et al.. (1996). Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.. Journal of Clinical Investigation. 98(10). 2308–2314. 197 indexed citations
14.
Guttormsen, Hilde‐Kari, Carol J. Baker, Morven S. Edwards, Lawrence C. Paoletti, & Dennis L. Kasper. (1996). Quantitative Determination of Antibodies to Type III Group B Streptococcal Polysaccharide. The Journal of Infectious Diseases. 173(1). 142–150. 61 indexed citations
15.
Wessels, Michael R., et al.. (1995). Immunogenicity and Protective Activity in Animals of a Type V Group B Streptococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine. The Journal of Infectious Diseases. 171(4). 879–884. 42 indexed citations
16.
Madoff, Lawrence C., Lawrence C. Paoletti, J Y Tai, & D. L. Kasper. (1994). Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.. Journal of Clinical Investigation. 94(1). 286–292. 68 indexed citations
17.
Hervás, Juan A., et al.. (1993). Neonatal Group B Streptococcal Infection in Mallorca, Spain. Clinical Infectious Diseases. 16(5). 714–718. 23 indexed citations
18.
Paoletti, Lawrence C., Dennis L. Kasper, Francis Michon, et al.. (1992). Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates.. Journal of Clinical Investigation. 89(1). 203–209. 60 indexed citations
19.
Paoletti, Lawrence C., Michael R. Wessels, Francis Michon, Harold J. Jennings, & Dennis L. Kasper. (1992). Group B Streptococcus Type III Glycoconjugate Vaccines.. Trends in Glycoscience and Glycotechnology. 4(17). 269–278. 6 indexed citations
20.
Wessels, Michael R., Lawrence C. Paoletti, Dennis L. Kasper, et al.. (1990). Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.. Journal of Clinical Investigation. 86(5). 1428–1433. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026